Bellicum
Bellicum focuses on discovering and developing cellular immunotherapies for cancer and orphan inherited blood disorders.
Business Model:
Revenue: $11.8M
Employees: 2-10
Industries / Tags:
Detailed Bellicum Information
Geographic Data
Address: 3730 Kirby Drive,
City: Houston
State: TX
Zip: 77098
Country: US
Financial Info
Stage:
post ipo equity
Raised Last:
$25M
Raised Total:$290M
Social
Metrics
4,245,900Website Global Rank
2,750Website Monthly Traffic
Twitter Followers
Description
Bellicum focuses on discovering and developing cellular immunotherapies for cancer and orphan inherited blood disorders.
Contact Phone:
+12814543424
Contact Email:
Bellicum went public on 11/19/2014 on the NASDAQ
Listed Exchange:
NASDAQ
IPO Date:
11/19/2014
Ticker Symbol:
BLCM
Amount Raised:
$115M
Live
Opened: -/share
| EBITDA | - |
| Total Cash | - |
| Total Debt | - |
| Total Revenue | - |
| Total Profit (Gross) | - |
| PE Ratio | - |
| Announced Date | Company | Transaction | Money Raised |
|---|
| Announced Date | Name | Price |
|---|
Employee Departments
Employee States
|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|
